Skip to content
Gibson Dunn home
  • Home
  • About
  • Subscribe
Biotech Briefings
June 18, 2024

Delaware Court of Chancery Opines on Meaning of ‘Commercially Reasonable Efforts’ in Pharmaceutical Earn-Out Provision

Ryan Murr, Karen Spindler, Todd Trattner, Marina Szteinbok and Artin Au-Yeung are the authors of “Delaware Court of Chancery Opines on Meaning of ‘Commercially Reasonable Efforts’ in Pharmaceutical Earn-Out Provision” [PDF] published by the Deal Lawyers in its May-June 2024 issue.

  • RSS Feed

Topics

  • Delaware Law
  • M&A
  • Subscribe
  • Privacy Statement
  • Cookie Notice
  • Contact Us

© 2026 Gibson Dunn & Crutcher LLP. All rights reserved. For contact and other information, please visit us at www.gibsondunn.com.